ScoreWhy is Glycorex Transplantation AB ?
Unrated Stock - No Analysis Available
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Glycorex Transplantation AB for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Glycorex Transplantation AB
-100.0%
1.19
113.85%
OMX Stockholm 30
26.99%
0.24
18.06%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.54%
EBIT Growth (5y)
3.80%
EBIT to Interest (avg)
-13.86
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
0.86
Tax Ratio
0.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.72
EV to EBIT
-12.00
EV to EBITDA
41.15
EV to Capital Employed
3.19
EV to Sales
2.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-26.62%
ROE (Latest)
-22.35%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
NET PROFIT(HY)
Higher at SEK -6.2 MM
-20What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 157.59% (YoY
CASH AND EQV(HY)
Lowest at SEK 18.72 MM
NET SALES(Q)
Lowest at SEK 8.72 MM
OPERATING PROFIT(Q)
Lowest at SEK -1.24 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -14.23 %
PRE-TAX PROFIT(Q)
Lowest at SEK -3.52 MM
NET PROFIT(Q)
Lowest at SEK -3.52 MM
EPS(Q)
Lowest at SEK -0.04
Here's what is not working for Glycorex Transplantation AB
Pre-Tax Profit
At SEK -3.52 MM has Fallen at -80.81%
over average net sales of the previous four periods of SEK -1.94 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (SEK MM)
Net Profit
At SEK -3.52 MM has Fallen at -82.12%
over average net sales of the previous four periods of SEK -1.93 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Net Sales
Lowest at SEK 8.72 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (SEK MM)
Operating Profit
Lowest at SEK -1.24 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (SEK MM)
Operating Profit Margin
Lowest at -14.23 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at SEK -3.52 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (SEK MM)
Net Profit
Lowest at SEK -3.52 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (SEK MM)
EPS
Lowest at SEK -0.04
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (SEK)
Cash and Eqv
Lowest at SEK 18.72 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 157.59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
